{
}
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
UBS projects the S&P 500 will reach 6,400 by the end of 2025. This optimistic forecast reflects the firm's confidence in the market's growth potential over the next few years.
UBS has raised its S&P 500 price target for year-end 2025 to 6,400, an 8% increase from the previous forecast, while also adjusting the 2024 target to 5,850. The bank anticipates a 9.2% upside driven by earnings growth and improving economic conditions, projecting EPS of $240, $257, and $275 for 2024, 2025, and 2026, respectively. Key factors include stable margins, revenue growth of 4.8% in 2025, and a slight rise in price-to-earnings multiples, although inflation risks could impact the outlook.
UBS has raised its year-end target for the S&P 500 to 5,850 points, up from 5,600, citing corporate earnings growth and favorable economic conditions. The index has surged 22.85% in 2024, reaching a record high of 5,859.85 points. UBS also increased its 2025 target to 6,400, driven by anticipated interest rate cuts and strong technology stock performance.
UBS Global Research has raised its year-end target for the S&P 500 to 5,850 points, up from 5,600, citing corporate earnings growth and favorable macroeconomic conditions. The index has surged 22.85% in 2024, reaching a record high of 5,859.85 points. Additionally, UBS increased its 2025 target to 6,400, driven by anticipated interest rate cuts and strength in technology stocks.
UBS Global Research has raised its year-end target for the S&P 500 to 5,850 points, up from 5,600, citing corporate profit growth and a supportive macroeconomic environment. The index has surged 22.85% in 2024, reaching a record high of 5,859.85 points. UBS also increased its 2025 target to 6,400, anticipating further gains driven by technology stocks and a series of interest rate cuts by the Federal Reserve.
Johnson & Johnson reported strong sales growth for its cancer therapy Carvykti and immune disease drug Tremfya in Q3, as new approvals expanded their market reach. This growth comes as the company braces for biosimilar competition to its second-best-selling drug, Stelara, expected in January 2025, which saw a 7% sales decline due to insurer rebates. J&J remains optimistic, raising its operational sales guidance for the year, with plans to expand Tremfya into Crohn’s disease and Carvykti's recent FDA approval for earlier treatment in multiple myeloma.
Frazier Healthcare Partners has acquired DirectMed Imaging, a prominent provider of aftermarket parts and repairs for diagnostic imaging equipment. This partnership aims to enhance DirectMed's growth and market leadership by leveraging Frazier's extensive healthcare expertise and resources. DirectMed, which supports healthcare organizations by extending the life of imaging equipment, plans to expand its capabilities in various imaging modalities.
UBS has been criticized by the Swiss financial supervisory authority, Finma, for its inadequate emergency plans following its takeover of Credit Suisse. The bank must revise these plans by the end of 2026 to ensure an orderly wind-up in a crisis, amid increasing international pressure for stricter capital requirements and detailed separation strategies. This revision could incur costs in the hundreds of millions and impact profitability and dividend policies, but UBS is cooperating with authorities and views the review as a chance to enhance its resilience.
The Federal Trade Commission has finalized updates to premerger notification requirements for healthcare companies, increasing the information needed for merger and acquisition reviews. This change, the first in 45 years, aims to enhance antitrust assessments amid rising deal complexity, despite pushback from the American Hospital Association, which criticized the increased reporting burden as excessive. The new rules will take effect 90 days after publication in the federal register.
Activists in the US are urging the Department of Labor to revoke UBS's license to manage pension fund assets due to the bank's extensive history of criminal offenses, including $20 billion in fines for 96 financial crimes since 2000. The department is reassessing its rules regarding banks with criminal records, which could impact UBS's ability to operate in the $30 trillion US pension fund market. A decision on UBS's exemption application is pending, with calls for accountability in the banking sector.
USA
Country
15:09 15.10.2024
United States Dollar
UBS SA
USA
Strategists outlined several key factors that are expected to drive the S&P 500’s performance.
15:05 15.10.2024
United States Dollar
S&P Global Inc.
UBS SA
Federal Reserve Bank of Boston N.A.
USA
Jerome Powell
Jonathan Golub
Show more
14:21 15.10.2024
United States Dollar
S&P Global Inc.
UBS SA
Federal Reserve Bank of Boston N.A.
USA
Jerome Powell
Jonathan Golub
Show more
14:21 15.10.2024
United States Dollar
S&P Global Inc.
UBS SA
Federal Reserve Bank of Boston N.A.
USA
Mrigank Dhaniwala
Jerome Powell
Jonathan Golub
Show more
14:21 15.10.2024
United States Dollar
Johnson & Johnson
AbbVie Inc.
Amgen Inc.
USA
Joe Wolk
Jennifer Taubert
Show more
14:04 15.10.2024
Vertiv Holdings Co
Frazier Healthcare Partners
LBN Medical ApS
DirectMed Imaging
NMS Capital LP
USA
DNK
Brad de Koning
Tanner LoRusso
Kent Berkley
Show more
14:00 15.10.2024
Swiss Franc
United States Dollar
Reuters Ltd.
Credit Suisse Anlagestiftung
UBS SA
US Federal Reserve
Bank of England
CHE
USA
GBR
UBS CEO Ralph Hamers
Credit Suisse
Finma
Show more
13:40 15.10.2024
13:30 15.10.2024
12:53 15.10.2024
Trending
Subcategory:
Cryptocurrency Markets
Stock Market Updates
Cryptocurrency Trends
Central Bank Actions
Cryptocurrency & Blockchain Regulations
Market Sentiment Analysis
Inflation Rates & CPI Data
Corporate Responsibility & ESG
Banking Regulations
Decentralized Finance (DeFi) Innovations
SEC & Financial Compliance
Cryptocurrency Regulations
Tokenomics and Crypto Economics
Blockchain Technology Adoption
Mergers & Acquisitions
Market Analysis and Predictions
Anti-Money Laundering (AML) Regulations
Real Estate Investments
Cryptocurrency Developments
Banking & Investment Regulations
Countries:
Companies:
Currencies:
People:
Coinbase Global, Inc.
JPMorgan Chase & Co.
Solana USD
Apple Inc.
Ripples USD
MicroStrategy Inc
BlackRock, Inc.
NVIDIA Corporation
Bitwise Bitcoin ETF
Grayscale Litecoin Trust
Chainlink USD
VanEck Vietnam ETF
Intesa Sanpaolo
KB Home
Wells Fargo & Company
Ethereum USD
Kraken Energy Corp.
Coinbase Global Inc
The Goldman Sachs Group, Inc.
Tether USDt CNY
United States Dollar
Euro
Swiss Franc
Chinese Yuan
British Pound Sterling
Canadian Dollar
Indian Rupee
Japanese Yen
Hong Kong Dollar
Thai Baht
Australian Dollar
South Korean Won
Swedish Krona
Danish Krone
Mongolian Tögrög
Indonesian Rupiah
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.